|
Volumn 16, Issue 1, 2002, Pages 154-156
|
High incidence of point mutations of p53 suppressor oncogene in patients with myelodysplastic syndrome among atomic-bomb survivors: A 10-year follow-up [3]
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DNA;
ATOMIC BOMB SURVIVOR;
BONE MARROW BIOPSY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DNA DETERMINATION;
DNA SEQUENCE;
FEMALE;
FOLLOW UP;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INCIDENCE;
KARYOTYPING;
LETTER;
MALE;
MYELODYSPLASTIC SYNDROME;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
SEQUENCE ANALYSIS;
SINGLE STRAND CONFORMATION POLYMORPHISM;
TUMOR SUPPRESSOR GENE;
AMINO ACID SUBSTITUTION;
ANEMIA, REFRACTORY;
ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS;
CELL TRANSFORMATION, NEOPLASTIC;
COHORT STUDIES;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
FEMALE;
FOLLOW-UP STUDIES;
GENES, P53;
HUMANS;
INCIDENCE;
KARYOTYPING;
LEUKEMIA, RADIATION-INDUCED;
MALE;
MIDDLE AGED;
MUTATION, MISSENSE;
MYELODYSPLASTIC SYNDROMES;
NUCLEAR WARFARE;
POINT MUTATION;
PRELEUKEMIA;
SURVIVORS;
|
EID: 0036153344
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2402277 Document Type: Letter |
Times cited : (11)
|
References (8)
|